Medline, Inc. (MDLN)
44.48
+1.08
(+2.49%)
USD |
NASDAQ |
Apr 30, 16:00
44.48
0.00 (0.00%)
After-Hours: 16:30
Medline EPS Diluted (Quarterly) : 0.2241 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| TransMedics Group, Inc. | 2.576 |
| Abbott Laboratories | 0.6165 |
| Boston Scientific Corp. | 0.897 |
| Stryker Corp. | 2.197 |
| Globus Medical, Inc. | 1.029 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 180.00M |
| Revenue (Quarterly) | 7.787B |
| Total Expenses (Quarterly) | 7.605B |
| Enterprise Value | 54.85B |
| Gross Profit Margin (Quarterly) | 22.32% |
| Profit Margin (Quarterly) | 2.31% |
| Earnings Yield | 3.25% |
| Operating Earnings Yield | 6.32% |
| Normalized Earnings Yield | 3.299 |